Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001185185-24-000811
Filing Date
2024-08-14
Accepted
2024-08-14 16:23:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A bradburya20240813c_sc13da.htm SC 13D/A 43279
  Complete submission text file 0001185185-24-000811.txt   44984
Mailing Address 10224 FALLS ROAD POTOMAC MD 20854
Business Address 10224 FALLS ROAD POTOMAC MD 20854 301-983-0998
IGC Pharma, Inc. (Subject) CIK: 0001326205 (see all company filings)

EIN.: 202760393 | State of Incorp.: MD | Fiscal Year End: 0331
Type: SC 13D/A | Act: 34 | File No.: 005-81669 | Film No.: 241208362
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address UNIT 5106-7, 51ST FLOOR THE CENTER 99 QUEENS ROAD CENTRAL CENTRAL K3 999077
Business Address UNIT 5106-7, 51ST FLOOR THE CENTER 99 QUEENS ROAD CENTRAL CENTRAL K3 999077 85239083300
Bradbury Strategic Investment Fund A (Cayman Islands Registration No. CR-359857) (Filed by) CIK: 0002022777 (see all company filings)

EIN.: 000000000
Type: SC 13D/A